Frost & Sullivan Recognizes Prodia the CRO with the 2026 Southeast Asian Contract Research Organization Customer Value Leadership Recognition
10 Sep 2026
“Prodia the CRO has distinguished itself by combining deep local regulatory expertise with an integrated clinical research ecosystem and internationally aligned quality practices. Its ability to bring together clinical trial management, laboratory support, site management, regulatory consulting, consumer product clinical assessment, and emerging pharmacovigilance capabilities enables sponsors to simplify study execution while maintaining strong standards of quality and compliance.”
— Unmesh Lal, Vice President, Frost & Sullivan
Read the full announcement here:
Related News
News08 September 2026
Prodia Wins 2026 Customer Journey Experience Award, Consistently Prioritizing Excellent Customer Journey in Diagnostic Laboratory Services
Prodia received the 2026 CJX Award for its commitment to providing quality customer experience and clinical laboratory services.
News31 Agustus 2026
ProSTEM Receives Sharia Compliance Recommendation from LPPOM MUI
ProSTEM Receives Sharia Compliance Recommendation from LPPOM MUI. The development of stem cell-based therapies in Indonesia continues to show progress.
News20 Agustus 2026
To Improve Occupational Health and Safety Standards, PT Prodia Diagnostic Line Tbk (PRDL) Holds Emergency Response Simulations for Disasters and Fires
PT Prodia Diagnostic Line Tbk (Proline) reaffirmed its commitment to implementing an Occupational Safety and Health (K3) culture through an Earthquake and Fire Mitigation Emergency Response Simulation Training.